The invention provides a gene therapy method for delivering safe and effective, long-term amounts of GLP-1(7-37)-based proteins useful for treating Type I and Type II diabetes. The invention eliminates the need for subcutaneous injections and is able to provide tight glucose control.
申请公布号
WO9729180(A1)
申请公布日期
1997.08.14
申请号
WO1997US01978
申请日期
1997.02.06
申请人
ELI LILLY AND COMPANY;BORTS, TRACY, L.;BRODERICK, CAROL, L.;DIMARCHI, RICHARD, D.;GRINNELL, BRIAN, W.;MILLER, ANNE, R.
